Literature DB >> 19224388

Relationships between total/free prostate-specific antigen and prostate volume in Chinese men with biopsy-proven benign prostatic hyperplasia.

Qiqi Mao1, Xiangyi Zheng, Xiaolong Jia, Yuyong Wang, Jie Qin, Kai Yang, Yu Bai, Liping Xie.   

Abstract

OBJECTIVE: This study investigated relationships between total prostate-specific antigen (tPSA), free prostate-specific antigen (fPSA), and prostate volume (PV) in Chinese men with biopsy-proven BPH, and analyzed whether fPSA performed better than tPSA at estimating thresholds of PV.
MATERIALS AND METHODS: From 2003 to 2008, a total of 286 patients with a PSA less than 10 ng/ml and biopsy proven benign prostatic hyperplasia were included in this study. The relationships between age, PV, tPSA, and fPSA were analyzed using the Pearson correlation coefficient (r). Receiver-operating characteristic (ROC) curves were constructed to evaluate and compare the ability of serum tPSA and fPSA to estimate thresholds of PV in men with biopsy-proven BPH.
RESULTS: Among relationships between tPSA, fPSA, age, and PV, the highest correlation was found between fPSA and PV (r = 0.456, P < 0.001); the correlation coefficient was much lower between tPSA and PV (r = 0.278, P < 0.001). The ROC curves revealed that the performance of fPSA at predicting threshold prostate sizes (30, 40, and 50 ml) showed areas under the curve (AUC) ranging from 0.72 to 0.75, denoting better discrimination of PV than that achieved by use of tPSA.
CONCLUSION: Although tPSA significantly correlated with PV in Chinese men with biopsy-proven BPH, the correlation between fPSA and PV was much stronger, and fPSA performed significantly better than tPSA at predicting thresholds of PV. fPSA may be used to estimate PV and could be a useful tool in making therapeutic decisions in Chinese men with BPH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224388     DOI: 10.1007/s11255-009-9533-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  18 in total

1.  Natural history of prostatism: risk factors for acute urinary retention.

Authors:  S J Jacobsen; D J Jacobson; C J Girman; R O Roberts; T Rhodes; H A Guess; M M Lieber
Journal:  J Urol       Date:  1997-08       Impact factor: 7.450

2.  Correlation between serum prostate specific antigen and prostate volume in Taiwanese men with biopsy proven benign prostatic hyperplasia.

Authors:  Yu-Lung Chang; Alex T L Lin; Kuang-Kuo Chen; Yen-Hwa Chang; Howard H H Wu; Junne-Yih Kuo; William J S Huang; Shing-Hwa Lu; Yen-Shen Hsu; Hsiao-Jen Chung; Shyh-Chyi Chang
Journal:  J Urol       Date:  2006-07       Impact factor: 7.450

3.  Relationship of prostate-specific antigen and prostate volume in patients with biopsy proven benign prostatic hyperplasia.

Authors:  D A Hochberg; N A Armenakas; J A Fracchia
Journal:  Prostate       Date:  2000-12-01       Impact factor: 4.104

4.  Prediction of prostate volume based on total and free serum prostate-specific antigen: is it reliable?

Authors:  J Morote; G Encabo; M López; I M de Torres
Journal:  Eur Urol       Date:  2000-07       Impact factor: 20.096

5.  Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia.

Authors:  C G Roehrborn; P Boyle; A L Gould; J Waldstreicher
Journal:  Urology       Date:  1999-03       Impact factor: 2.649

6.  Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group.

Authors:  C G Roehrborn; J D McConnell; M Lieber; S Kaplan; J Geller; G H Malek; R Castellanos; S Coffield; B Saltzman; M Resnick; T J Cook; J Waldstreicher
Journal:  Urology       Date:  1999-03       Impact factor: 2.649

7.  Comparison of the cellular composition of benign prostatic hyperplasia in Chinese and Caucasian-American men.

Authors:  H Lepor; E Shapiro; B Wang; Y C Liang
Journal:  Urology       Date:  1996-01       Impact factor: 2.649

Review 8.  Human benign prostatic hyperplasia: etiological considerations.

Authors:  P C Walsh
Journal:  Prog Clin Biol Res       Date:  1984

9.  Prostate-specific antigen, prostate volume and transition zone volume in Japanese patients with histologically proven benign prostatic hyperplasia.

Authors:  Y Furuya; S Ohta; N Sato; T Kotake; M Masai
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

10.  Relationship between prostate specific antigen and indexes of prostate volume in Japanese men.

Authors:  Amit Gupta; Corinne Aragaki; Momokazu Gotoh; Naoya Masumori; Shinichi Ohshima; Taiji Tsukamoto; Claus G Roehrborn
Journal:  J Urol       Date:  2005-02       Impact factor: 7.450

View more
  9 in total

Review 1.  An overview of prostate diseases and their characteristics specific to Asian men.

Authors:  Shu-Jie Xia; Di Cui; Qi Jiang
Journal:  Asian J Androl       Date:  2012-02-06       Impact factor: 3.285

2.  A novel equation and nomogram including body weight for estimating prostate volumes in men with biopsy-proven benign prostatic hyperplasia.

Authors:  Yasukazu Nakanishi; Hitoshi Masuda; Satoru Kawakami; Mizuaki Sakura; Yasuhisa Fujii; Kazutaka Saito; Fumitaka Koga; Masaya Ito; Junji Yonese; Iwao Fukui; Kazunori Kihara
Journal:  Asian J Androl       Date:  2012-07-09       Impact factor: 3.285

3.  Office evaluation of male patients with lower urinary tract symptoms.

Authors:  Shahin Tabatabaei; Saman Shafaat Talab; Mahdi Zangi; Henry H Woo
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

4.  Predicting the resected tissue weight from a digital rectal examination and total prostate specific antigen level before transurethral resection of the prostate.

Authors:  Ahmed M Harraz; Ahmed El-Assmy; Mohamed Tharwat; Ahmed M Elshal; Ahmed R El-Nahas; Tamer S Barakat; Mohamed M Elsaadany; Samer El-Halwagy; El Housseiny I Ibrahiem
Journal:  Arab J Urol       Date:  2014-11-11

5.  Ethnicity is an independent determinant of age-specific PSA level: findings from a multiethnic Asian setting.

Authors:  Jasmine Lim; Nirmala Bhoo-Pathy; Selvalingam Sothilingam; Rohan Malek; Murali Sundram; Badrul Hisham Bahadzor; Teng Aik Ong; Keng Lim Ng; Sivaprakasam Sivalingam; Azad Hassan Abdul Razack
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

6.  Significant Diagnostic Value of Free-Serum PSA (FPSA)/Prostate-Specific Antigen Density (PSAD) and (F/T)/PSAD for Prostate Cancer of the Chinese Population in a Single Institution.

Authors:  Li-Bin Nan; Xiao-Tao Yin; Jiang-Ping Gao
Journal:  Med Sci Monit       Date:  2019-11-06

7.  Machine learning model for the prediction of prostate cancer in patients with low prostate-specific antigen levels: A multicenter retrospective analysis.

Authors:  Xiaobin Deng; Tianyu Li; Linjian Mo; Fubo Wang; Jin Ji; Xing He; Bashir Hussein Mohamud; Swadhin Pradhan; Jiwen Cheng
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

8.  Free prostate-specific antigen provides more precise data on benign prostate volume than total prostate-specific antigen in korean population.

Authors:  Hoon Choi; Jae Young Park; Ji Sung Shim; Jae Heon Kim; Jae Hyun Bae
Journal:  Int Neurourol J       Date:  2013-06-30       Impact factor: 2.835

9.  Prostate-specific antigen mass and free prostate-specific antigen mass for predicting the prostate volume of korean men with biopsy-proven benign prostatic hyperplasia.

Authors:  Tae Yong Park; Ji Yun Chae; Jong Wook Kim; Jin Wook Kim; Mi Mi Oh; Cheol Yong Yoon; Du Geon Moon
Journal:  Korean J Urol       Date:  2013-09-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.